Poster Presentations: Posters Thursday, 14 April 2016: Viral hepatitis: Hepatitis C – clinical (new compounds, resistance)
In a 5-Day Monotherapy Trial, MK-8408 Demonstrates Potent Antiviral Activity and Improved Resistance Profile in HCV Patients with Genotypes 1, 2, and 3 Infections